Elacestrant
About
Therapy type: Hormone therapy
Therapy strategy: ER signaling inhibition
Mappings
NCI Thesaurus: Elacestrant (coding:ncit:C120211)
RxNorm: elacestrant (coding:rxcui:2628469, coding:omop:1301646)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | ER positive, ESR1 activating variants, HER2-negative | Invasive Breast Carcinoma | Elacestrant | |
| EMA (1) | FGFR2::v | Cholangiocarcinoma | Elacestrant | |
| EMA (1) | FGFR2 rearrangements | Cholangiocarcinoma | Elacestrant |